Four of the human volunteers were found to have bacterial colonies in their colons that were rich in Prevotella
CMS is proposing temporary expansions of Medicare and Medicaid coverage of GLP-1s for obesity through demonstration programs CMS initially proposed a two-step approach to expanding coverage of GLP-1s for obesity in Medicare a temporary payment demonstration for 2026, known as the Medicare GLP-1 Bridge, and a new Center for Medicare and Medicaid Innovation (CMMI) model, known as the BALANCE Model, that was originally scheduled to begin in January 2027 and end in December 2031
Jorsal A, Wiggers H, Holmager P, Nilsson B, Nielsen R, Boesgaard TW, Kumme A, Moller JE, Videbaek L, Kistorp C, Gustafsson I, Tarnow L, Flyvbjerg A
Figure 3: The mechanism of entry of glucose into insulin-sensitive cells mediated by the insulin hormone
It also has benefits that extend beyond weight loss, including improvement of cholesterol levels, and decreasing blood pressure in those with high blood pressure and those with cardiovascular disorders
